You have 9 free searches left this month | for more free features.

Danirixin

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pulmonary Disease, Chronic Obstructive Trial in Overland Park (Danirixin, Omeprazole)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Overland Park, Kansas
    GSK Investigational Site
Apr 27, 2021

Pulmonary Disease, Chronic Obstructive Trial in Dundee (Danirixin, Placebo, Rescue medication)

Terminated
  • Pulmonary Disease, Chronic Obstructive
  • Danirixin
  • +3 more
  • Dundee, United Kingdom
    GSK Investigational Site
Feb 26, 2021

Virus Diseases Trial in Worldwide (Danirixin 15 mg FBE, Danirixin 50 mg FBE, Placebo)

Terminated
  • Virus Diseases
  • Danirixin 15 mg FBE
  • +3 more
  • Stamford, Connecticut
  • +7 more
Nov 20, 2020

Pulmonary Disease, Chronic Obstructive Trial in United States (Danirixin 35 mg tablets, Placebo, Metered dose inhaler (MDI)

Terminated
  • Pulmonary Disease, Chronic Obstructive
  • Danirixin 35 mg tablets
  • +3 more
  • Birmingham, Alabama
  • +10 more
Jul 14, 2020

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (Danirixin, Danirixin matching , Standard of care)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Danirixin
  • +3 more
  • Birmingham, Alabama
  • +63 more
Oct 6, 2020

Pulmonary Disease, Chronic Obstructive Trial in Tokyo (GSK1325756H, Placebo)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Tokyo, Japan
  • +1 more
Jan 14, 2019

Virus Diseases Trial in Australia, South Africa, United States (GSK1325756 (Danirixin), Placebo To Match GSK1325756, Oseltamivir

Completed
  • Virus Diseases
  • GSK1325756 (Danirixin)
  • +3 more
  • Palmetto Bay, Florida
  • +32 more
Jul 10, 2019

Pulmonary Disease, Chronic Obstructive Trial in Overland Park (Danirixin HBr 50 mg IR Tablet, Danirixin FB 50 mg IR Tablet,

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Danirixin HBr 50 mg IR Tablet
  • +2 more
  • Overland Park, Kansas
    GSK Investigational Site
Jul 20, 2018

Pulmonary Disease, Chronic Obstructive Trial in Germany, United States (Danirixin, Placebo)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Danirixin
  • Placebo
  • Birmingham, Alabama
  • +15 more
Jun 13, 2017

Infections, Respiratory Syncytial Virus Trial in Syracuse (Danirixin, CXCL1)

Completed
  • Infections, Respiratory Syncytial Virus
  • Danirixin
  • CXCL1
  • Syracuse, New York
    GSK Investigational Site
May 5, 2017